Active Ingredient: Nalbuphine
Nalbuphine is indicated for the short-term relief of moderate to severe pain. It can also be used for pre- and post-operative analgesia.
For this indication, competent medicine agencies globally authorize below treatments:
Subcutaneous
0.4 - 0.8 mg per kg of body weight
From 0.1 To 0.2 mg per kg of body weight 4 time(s) per day every day
The usual recommended dose for children is 0.1-0.2 mg/kg body weight. This dose may be administered intravenously, intramuscularly or subcutaneously. Intramuscular as well as subcutaneous administration might be painful and should be avoided in children.
The dose may be repeated after 3 to 6 hours, if necessary. The single maximum dose is fixed with 0.2 mg nalbuphine hydrochloride per kilogram body weight.
There are no adequate data for the treatment of children younger than 1.5 years.
Intramuscular
0.4 - 0.8 mg per kg of body weight
From 0.1 To 0.2 mg per kg of body weight 4 time(s) per day every day
The usual recommended dose for children is 0.1-0.2 mg/kg body weight. This dose may be administered intravenously, intramuscularly or subcutaneously. Intramuscular as well as subcutaneous administration might be painful and should be avoided in children.
The dose may be repeated after 3 to 6 hours, if necessary. The single maximum dose is fixed with 0.2 mg nalbuphine hydrochloride per kilogram body weight.
There are no adequate data for the treatment of children younger than 1.5 years.
Intravenous
0.4 - 0.8 mg per kg of body weight
From 0.1 To 0.2 mg per kg of body weight 4 time(s) per day every day
The usual recommended dose for children is 0.1-0.2 mg/kg body weight. This dose may be administered intravenously, intramuscularly or subcutaneously. Intramuscular as well as subcutaneous administration might be painful and should be avoided in children.
The dose may be repeated after 3 to 6 hours, if necessary. The single maximum dose is fixed with 0.2 mg nalbuphine hydrochloride per kilogram body weight.
There are no adequate data for the treatment of children younger than 1.5 years.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
